Caribou Biosciences, Inc. (CRBU) vs NRx Pharmaceuticals, Inc. (NRXP)
A side-by-side comparison of Caribou Biosciences, Inc. and NRx Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRBU
Caribou Biosciences, Inc.
$1.14HealthcareDelayed quote: Oct 6, 2026, 3:45 PM EDT
NRXP
NRx Pharmaceuticals, Inc.
$2.95HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT
Total return — CRBU vs NRXP
growth of $100 · dividends reinvested · last 5yCRBU -92.7% (-40.8%/yr)NRXP -97.2% (-51.0%/yr)CRBU compounded faster over this window
CRBU NRXP
CRBU vs NRXP: by the numbers
- •NRXP is the larger company ($128M vs $113M market cap).
- •Both run net losses; NRXP's is the smaller (-691.81% vs -1030.42% net margin).
Metrics side by side
Valuation
| Metric | CRBU | NRXP |
|---|---|---|
| P/S ratio | 11.27 | 37.57 |
| P/B ratio | 1.15 | N/A |
Profitability
| Metric | CRBU | NRXP |
|---|---|---|
| Gross margin | 67.34% | 58.78% |
| Operating margin | -1220.49% | -1324.41% |
| Net margin | -1030.42% | -691.81% |
| ROE | -105.40% | N/A |
| ROIC | -87.72% | N/A |
Growth (annualized)
| Metric | CRBU | NRXP |
|---|---|---|
| Revenue CAGR (5Y) | -2.03% | N/A |
| Total return CAGR (5Y) | -44.43% | -49.61% |
Frequently asked
- How have CRBU and NRXP total returns compared?
- Over the past 5 years, CRBU delivered -44.43% and NRXP delivered -49.61% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.